High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting. (2014)

First Author: Fuchs EM
Attributed to:  MRC Brain Banks: Joint application to underpin neuroscience research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ijc.28660

PubMed Identifier: 24311197

Publication URI: http://europepmc.org/abstract/MED/24311197

Type: Journal Article/Review

Volume: 135

Parent Publication: International journal of cancer

Issue: 1

ISSN: 0020-7136